Initiator Pharma A/S (STO:INIT)
Sweden · Delayed Price · Currency is SEK 2.290
-0.140 (-5.76%)
Jul 24, 2026, 5:24 PM CET
Initiator Pharma Market Cap
Initiator Pharma has a market cap or net worth of 166.34 million as of July 24, 2026. Its market cap has decreased by -29.57% in one year.
Market Cap
166.34M
Enterprise Value
148.31M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.29
ChartMarket Cap Chart
Since March 16, 2017, Initiator Pharma's market cap has increased from 50.37M to 166.34M, an increase of 230.26%. That is a compound annual growth rate of 13.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 23, 2026 | 166.34M | -17.91% |
| Dec 30, 2025 | 202.62M | -47.31% |
| Dec 30, 2024 | 384.53M | -20.69% |
| Dec 29, 2023 | 484.84M | 52.80% |
| Dec 30, 2022 | 317.31M | -10.94% |
| Dec 30, 2021 | 356.31M | 167.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 16, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xbrane Biopharma AB | 206.05M |
| IRLAB Therapeutics AB | 189.46M |
| Elicera Therapeutics AB | 175.52M |
| Simris Group AB (PUBL) | 174.12M |
| Xintela AB | 162.78M |
| Diamyd Medical AB | 162.42M |
| Nanologica AB | 144.00M |
| Active Biotech AB | 142.35M |